Academic & Community Cancer Research United

Vaccines and cancer recurrence: What's the connection? Tune in to our latest podcast, as Dr. Keith Knutson unpacks his pivotal work on immunotherapy for breast and ovarian cancers, striving for a relapse-free future after conventional treatments. buff.ly/3K2L9ih #BCSM #BC

Plug into our latest podcast episode and delve into the ACCRU neoadjuvant breast cancer trial, EVANGELINE. Our host chats with Dr. Matthew Goetz, Director of the Mayo Clinic Breast Cancer SPORE & Co-Leader of the Women's Cancer Program. buff.ly/3VbdytI #BCSM #BC

National Hereditary Cancer Week is here. Get clarity on caring for those with genetic mutations linked to ovarian cancer from an expert OBGYN PA. Read the Q&A: buff.ly/3sJ1pCf #hereditarycancer #OvarianCancer #GeneticHealth #CancerCare #AskTheExpert #WomensHealth

@GIcancerDoc @mpgoetz @CharlesLoprinzi

September spotlights #GynecologicCancerAwareness. Dr. Kristina Butler from Mayo Clinic breaks down top questions on Cervical Cancer. Stay informed, watch now: buff.ly/3R837ae #AskTheExpert #CancerAwareness #WomensHealth #KnowTheFacts #CervicalCancer

On the latest podcast, ACCRU's Dr. Toni Choueiri shines a light on the groundbreaking METEOR trial and the promising horizon of GU therapies. Tune in: buff.ly/40loRBZ #GUCancer #GenitourinaryCancer #METEORTrial #CancerInnovation @DrChoueiri @GIcancerDoc @mpgoetz

@GIcancerDoc @mpgoetz @CharlesLoprinzi

September is #ProstateCancerAwareness Month. Did you know that exercise and physical activity can potentially improve outcomes for patients? Learn more from this insightful article and video. buff.ly/461Cw35 #ProstateCancer #excerciseandcancer #cancertherapy

@GIcancerDoc @mpgoetz @CharlesLoprinzi

Tomorrow marks World Lymphoma Awareness. Unravel the mystery of Lymphoma with hematologist Dr. Stephen Ansell. Be in the know: buff.ly/34OZZHu #Lymphoma #LymphomaAwareness #LymphomaSymptoms

Did you know 19,000+ women in the U.S. will be diagnosed with #OvarianCancer this year, and nearly 13,000 will sadly lose the battle? This Ovarian Cancer Awareness Month, arm yourself with knowledge. Learn the symptoms and risks now: buff.ly/485gmOY #OC #OCSM

@GIcancerDoc @mpgoetz @CharlesLoprinzi

Dr. Jian Campian shares invaluable wisdom for early-career investigators on our latest podcast episode! Discover the power of mentorship and the essence of staying motivated. A must-listen for rising investigators as well as mentors in the field! buff.ly/3K4vWQA #cancer

Thyroid cancer is a top cancer diagnosis for those aged 15-29! This September, learn more about the unique needs of the #AYA community during #ThyroidCancerAwarenessMonth. buff.ly/3R5tHB1 #KnowTheFacts #StayAware #thyroidcancer #thyroidcancerresearch

@GIcancerDoc @mpgoetz @CharlesLoprinzi

How does ACCRU serve its members? To help you understand, read on for answers to our most commonly asked questions. buff.ly/43x4Us7 #cancerresearch #cancertrials

@GIcancerDoc @mpgoetz @CharlesLoprinzi

ACCRU-BR-1701 hypothesizes that TPIV100, in combination with ado-trastuzumab emtansine will improve outcome measured by invasive diseases free survival in HER2-positive breast cancer patients with residual disease after neoadjuvant chemotherapy. buff.ly/3pXvQ6I #BC #BCSM

@GIcancerDoc @mpgoetz @CharlesLoprinzi

In our latest podcast, medical neuro-oncologist Dr. Campian shares her experience in brain cancer research and discusses her current trial in development, a randomized open label Phase II study in patients with recurrent glioblastoma. buff.ly/3K4vWQA #braincancer